Akero Therapeutics Inc Financial Flexibility Index
Akero Therapeutics Inc financial flexibility index. Akero Therapeutics Inc (AKRO) has a Financial Flexibility Index of -1.40x as of September 2025. Free cash flow of $-67.17 Million (operating CF $-67.17 Million minus capex $0.00) represents -1% of total liabilities ($47.94 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Akero Therapeutics Inc (2017–2024)
Financial flexibility index of Akero Therapeutics Inc from 2017 to 2024. Historical Financial Flexibility Index trend for Akero Therapeutics Inc across 8 annual periods. Explore AKRO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Akero Therapeutics Inc Financial Flexibility Index by Year (2017–2024)
Akero Therapeutics Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for Akero Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Akero Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.02x | $-229.11 Million | $-230.11 Million | $75.77 Million | ▲ +6.5% |
| 2023 | -3.23x | $-145.37 Million | $-145.37 Million | $44.97 Million | ▼ -4.9% |
| 2022 | -3.08x | $-92.52 Million | $-92.52 Million | $30.01 Million | ▼ -2.3% |
| 2021 | -3.01x | $-79.68 Million | $-79.68 Million | $26.44 Million | ▲ +37.6% |
| 2020 | -4.83x | $-70.66 Million | $-70.80 Million | $14.63 Million | ▼ -27.9% |
| 2019 | -3.78x | $-35.48 Million | $-35.63 Million | $9.39 Million | ▼ -128104.4% |
| 2018 | 0.00x | $375.00K | $-4.62 Million | $127.07 Million | ▲ +100.4% |
| 2017 | -0.81x | $-4.23 Million | $-4.38 Million | $5.22 Million | — |